Phase 3CompletedAge-related condition
A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men (inTUne)
A Phase 3, Randomized, Active-controlled, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
- Sponsor
- Clarus Therapeutics, Inc. (Industry)
- Enrolment
- 222 enrolled
- Conditions
- Hypogonadism
- Interventions
- Oral Testosterone Undecanoate; Axiron Testosterone Topical Solution
- Ages
- adults, older adults
- Registry
- NCT02722278
Full record on ClinicalTrials.gov
From the registry
A Phase 3, Randomized, Active-controlled, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Primary outcomes
- Number of Oral TU Treated Subjects Who Have a Total T Cavg in the Eugonadal Range of 252 to 907 ng/dL at Visit 7
History
Results first posted
Last registry update
Primary completion
Registered
Started